click below
click below
Normal Size Small Size show me how
Pharm Ch 15
Brain Disorders - definitions
| Term | Definition |
|---|---|
| Schizophrenia | Split of loss of reality |
| Depression | Mood disorder characterized by low levels of norepinephrine and serotonin in the CNS |
| Bipolar | Mental health condition characterized by significant mood swings that include emotional highs (mania or hypomania) and lows (depression) |
| Akinesia | Loss of voluntary movement |
| Akathisia | Inability to sit still |
| Tardive dyskinesia | Involuntary repetitive movements, often affecting the face, mouth, and extremities |
| Extrapyramidal effects | A group of symptoms related to motor control that arise from the use of certain medication, particularly antipsychotic drugs |
| Atypical antipsychotic | Antipsychotics that are less likely to cause certain extrapyramidal effects, aka second-generation antipsychotic agents |
| Typical antipsychotic | Considered first-generation antipsychotic agents |
| Prolong QT | An irregular heart rhythm. Patients that take drugs that prolong the QT interval need periodic ECGs and need to be careful with tachycardia |
| Trismus | A condition characterized by the inability to fully open the mouth due to muscle spasm, rigidity, or mechanical obstruction |
| Sialorrhea | Hypersalivation or drooling, the excessive production of saliva or the inability to effectively manage and swallow saliva |
| Ageusia | Complete loss of the sense of taste |
| GABA (Gamma-Aminobutryic Acid) | An inhibitory neurotransmitter that plays a role in mood and stress regulation. Imbalances have been implicated in various psychiatric disorders |
| Serotonin | Neurotransmitter that plays a key role in mood regulation, sleep, appetite, and other physiological processes. Low levels are most commonly associated with depression |
| SSRIs | Selective Serotonin Reuptake Inhibitor |
| SNRIs | Serotonin-Norepinephrine Reuptake Inhibitor |
| TCAs | Tricyclic Antidepressants |
| MAOIs | Monoamine Oxidase Inhibitors |